NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
VIR Vir Biotechnology
- 7.340
- -0.030-0.41%
Close Dec 20 16:00 ET
- 7.390
- +0.050+0.68%
Post 20:01 ET
1.01BMarket Cap-1.87P/E (TTM)
7.560High7.230Low3.75MVolume7.340Open7.370Pre Close27.48MTurnover4.05%Turnover RatioLossP/E (Static)137.72MShares13.09052wk High0.81P/B679.07MFloat Cap6.56052wk Low--Dividend TTM92.52MShs Float141.010Historical High--Div YieldTTM4.48%Amplitude6.560Historical Low7.337Avg Price1Lot Size
Vir Biotechnology News
Morgan Stanley Maintains Vir Biotechnology(VIR.US) With Hold Rating, Maintains Target Price $10
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), PTC Therapeutics (PTCT) and Vir Biotechnology (VIR)
J.P. Morgan Sticks to Their Hold Rating for Vir Biotechnology (VIR)
Leerink Partners Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $18
HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target
TD Cowen Maintains Vir Biotechnology(VIR.US) With Buy Rating
A Quick Look at Today's Ratings for Vir Biotechnology(VIR.US), With a Forecast Between $10 to $26
TD Cowen Keeps Their Buy Rating on Vir Biotechnology (VIR)
Vir Biotechnology: Hold Rating Amidst Promising HDV Study Results and Future HBV Developments
Vir Biotechnology Analyst Ratings
Barclays Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $26
J.P. Morgan Maintains Vir Biotechnology(VIR.US) With Hold Rating, Maintains Target Price $13
Analysts Conflicted on These Healthcare Names: Vir Biotechnology (VIR) and Moderna (MRNA)
HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target
Vir Biotechnology's Promising Hepatitis Programs and Strategic FDA Alignment Justify Buy Rating
Barclays Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $26
A Quick Look at Today's Ratings for Vir Biotechnology(VIR.US), With a Forecast Between $10 to $19
A Quick Look at Today's Ratings for Vir Biotechnology(VIR.US), With a Forecast Between $10 to $19
Vir Biotechnology Analyst Ratings
Needham Reiterates Buy on Vir Biotechnology, Maintains $19 Price Target
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.